Mega Genomics Limited (Stock Code: 06667) published its monthly return for January 2026, showing that the authorized share capital remained at 500,000,000 ordinary shares with a par value of US$0.0001 each, totaling US$50,000. The number of issued shares stood at 224,300,200—unchanged from the prior month—and included no treasury shares.

The return also confirmed that Mega Genomics Limited’s public float continued to meet the minimum prescribed threshold of 25%. No share options, warrants, convertibles, or other agreements impacting its share capital were recorded during the period.